Autolus Therapeutics plc

Hello ladies and gentlemen and welcome to the otolith therapeutic second quarter 2020 financial results conference call as a reminder this conference call is being recorded i would now like to turn the conference over to your host dr lucinda crabtree vice president investor relations please go ahead thank you crystal good morning or good afternoon everyone and thank you for taking part in today's call on the financial results and operational highlights for the second quarter of 2020

I am Lucinda Crabtree, Vice President of Investor Relations. With me today are Dr Christian Itin, our Chairman and Chief Executive Officer, and Andrew Oakley, our Chief Financial Officer. Before we begin, I would like to remind you that during this call we will be making forward-looking statements. All statements other than statements of historical facts contained in this presentation are forward-looking statements. Our actual results, performance or achievements may be materially different from those expressed or implied by the forward-looking statements. For a discussion of the risks and uncertainties relating to our business and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, please see the section titled Risk Factors in our annual report on Form 20-F filed on March 3, 2020 as amended, as well as discussions of potential risks and uncertainties and other important factors in our other periodic filings with the SEC. The forward-looking statements contained in this presentation reflect the company's views as of the date of this presentation regarding future events and the company does not assume any obligation to update any forward-looking statements. You should therefore not rely on these forward-looking statements as representing the company's views as of any date subsequent to the date of this presentation. On slide three, agenda, you'll see the agenda for today and it is as follows. Christian will provide a brief introduction and that will be followed by our operational highlights for the second quarter of 2020. Andrew will next discuss the company's financial results and then Christian will conclude with upcoming milestones and other concluding comments. And of course we will welcome your questions following our remarks. So with that I'd like to turn the call over to Christian.

All right. Well, thank you very much, Lucinda.